ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,41%
Bitcoin
62.911,99
0,04%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) News

IGMS IGM Biosciences Inc

10,07
0,64 (6,79%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:55:51
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
IGM Biosciences Inc IGMS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,64 6,79% 10,07 23:55:51
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,73 9,72 10,19 10,07 9,43
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.4.202414:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
10.4.202413:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
07.3.202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.3.202422:10EDGAR2Form 8-K - Current report
07.3.202422:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
06.3.202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202413:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
08.1.202415:00EDGAR2Form 8-K - Current report
04.1.202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202413:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
16.12.202301:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202301:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202301:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202323:36EDGAR2Form 144 - Report of proposed sale of securities
13.12.202323:33EDGAR2Form 144 - Report of proposed sale of securities
13.12.202323:30EDGAR2Form 144 - Report of proposed sale of securities
13.12.202323:27EDGAR2Form 144 - Report of proposed sale of securities
08.12.202322:05EDGAR2Form 8-K - Current report
05.12.202322:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
02.12.202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202311:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
30.11.202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202302:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21.11.202308:48PRNUSMedivir to present at the Erik Penser Bank Company Event
13.11.202323:08EDGAR2Form S-3 - Registration statement under Securities Act of..
13.11.202322:10EDGAR2Form 8-K - Current report
13.11.202322:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
13.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..
06.10.202301:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202301:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.10.202313:29PRNUSFostrox + Lenvima continues to show promising tumor control..
04.10.202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202301:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202301:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:14EDGAR2Form 8-K - Current report
03.10.202322:05GLOBEIGM Biosciences Announces Retirement of Chairman Michael..
02.10.202322:27EDGAR2Form 144 - Report of proposed sale of securities
06.9.202313:00GLOBEIGM Biosciences to Present at the Morgan Stanley 21st Annual..
03.8.202322:13EDGAR2Form 8-K - Current report
03.8.202322:10GLOBEIGM Biosciences Announces Second Quarter 2023 Financial..
03.8.202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19.7.202322:13EDGAR2Form SC 13D/A - General statement of acquisition of..

Kürzlich von Ihnen besucht

NASDAQ
IGMS
IGM Biosciences
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten